Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of …

E Barbato, M Azizi, RE Schmieder… - European Heart …, 2023 - academic.oup.com
Since the publication of the 2018 European Society of Cardiology/European Society of
Hypertension (ESC/ESH) Guidelines for the Management of Arterial Hypertension, several …

The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019)

S Umemura, H Arima, S Arima, K Asayama… - Hypertension …, 2019 - nature.com
The Japanese Society of Hypertension (JSH) revised the Guidelines for the Management of
Hypertension 2014 (JSH 2014), and published the JSH 2019. In the development of the JSH …

Resistant hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association

RM Carey, DA Calhoun, GL Bakris, RD Brook… - …, 2018 - Am Heart Assoc
Resistant hypertension (RH) is defined as above-goal elevated blood pressure (BP) in a
patient despite the concurrent use of 3 antihypertensive drug classes, commonly including a …

Endovascular ultrasound renal denervation to treat hypertension: the RADIANCE II randomized clinical trial

M Azizi, M Saxena, Y Wang, JS Jenkins, C Devireddy… - Jama, 2023 - jamanetwork.com
Importance Two initial sham-controlled trials demonstrated that ultrasound renal denervation
decreases blood pressure (BP) in patients with mild to moderate hypertension and …

Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry

F Mahfoud, M Böhm, R Schmieder… - European Heart …, 2019 - academic.oup.com
Aims Several studies and registries have demonstrated sustained reductions in blood
pressure (BP) after renal denervation (RDN). The long-term safety and efficacy after RDN in …

A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on …

MH Olsen, SY Angell, S Asma, P Boutouyrie, D Burger… - The Lancet, 2016 - thelancet.com
Executive summary Elevated blood pressure is the strongest modifiable risk factor for
cardiovascular disease worldwide. Despite extensive knowledge about ways to prevent as …

Effect of exercise training on ambulatory blood pressure among patients with resistant hypertension: a randomized clinical trial

S Lopes, J Mesquita-Bastos, C Garcia… - JAMA …, 2021 - jamanetwork.com
Importance Limited evidence suggests exercise reduces blood pressure (BP) in individuals
with resistant hypertension, a clinical population with low responsiveness to drug therapy …

Evaluation of adherence should become an integral part of assessment of patients with apparently treatment-resistant hypertension

E Berra, M Azizi, A Capron, A Høieggen, F Rabbia… - …, 2016 - Am Heart Assoc
298 Hypertension August 2016 drug adherence. Assessment of adherence is not part of
routine clinical practice and is seldom performed in studies, even those testing drugs or …

Clinical trial design principles and outcomes definitions for device-based therapies for hypertension: a consensus document from the hypertension academic research …

DE Kandzari, F Mahfoud, MA Weber, R Townsend… - Circulation, 2022 - Am Heart Assoc
The clinical implications of hypertension in addition to a high prevalence of both
uncontrolled blood pressure and medication nonadherence promote interest in developing …

Adherence to antihypertensive treatment and the blood pressure–lowering effects of renal denervation in the renal denervation for hypertension (DENERHTN) trial

M Azizi, H Pereira, I Hamdidouche, P Gosse… - Circulation, 2016 - Am Heart Assoc
Background: The DENERHTN trial (Renal Denervation for Hypertension) confirmed the
blood pressure–lowering efficacy of renal denervation added to a standardized stepped …